$CGC
Canopy Growth Corp

2020 Q2 Form 10-Q Financial Statement

#000156459020038957 Filed on August 10, 2020

View on sec.gov

Income Statement

Concept 2020 Q2 2019 Q2
Revenue $110.4M $90.48M
YoY Change 22.03% 249.14%
Cost Of Revenue $103.9M $72.19M
YoY Change 43.95% 438.75%
Gross Profit $6.495M $18.29M
YoY Change -64.49% 145.04%
Gross Profit Margin 5.88% 20.21%
Selling, General & Admin $135.4M $145.6M
YoY Change -7.04% 112.93%
% of Gross Profit 2084.56% 796.32%
Research & Development $8.500M
YoY Change 962.5%
% of Gross Profit 46.47%
Depreciation & Amortization $17.42M $13.59M
YoY Change 28.17% 116.01%
% of Gross Profit 268.13% 74.29%
Operating Expenses $178.9M $233.0M
YoY Change -23.23% 222.73%
Operating Profit -$172.4M -$214.7M
YoY Change -19.72% 231.68%
Interest Expense $1.155M $1.206M
YoY Change -4.23% -102.0%
% of Operating Profit
Other Income/Expense, Net $48.21M $32.77M
YoY Change 47.11% -1313.63%
Pretax Income -$131.4M -$183.8M
YoY Change -28.52% 96.14%
Income Tax -$3.038M $10.27M
% Of Pretax Income
Net Earnings -$108.5M -$185.9M
YoY Change -41.63% 107.28%
Net Earnings / Revenue -98.27% -205.42%
Basic Earnings Per Share -$0.30 -$0.54
Diluted Earnings Per Share -$0.30 -$0.54
COMMON SHARES
Basic Shares Outstanding 363.8M
Diluted Shares Outstanding 363.8M

Balance Sheet

Concept 2020 Q2 2019 Q2
SHORT-TERM ASSETS
Cash & Short-Term Investments $2.037B $3.141B
YoY Change -35.15% 377.41%
Cash & Equivalents $975.9M $1.817B
Short-Term Investments $1.061B $1.324B
Other Short-Term Assets $11.25M $124.1M
YoY Change -90.94% 243.77%
Inventory $389.8M $496.6M
Prepaid Expenses $51.20M
Receivables $42.22M $57.00M
Other Receivables $10.79M $45.80M
Total Short-Term Assets $2.614B $3.864B
YoY Change -32.36% 332.83%
LONG-TERM ASSETS
Property, Plant & Equipment $1.509B $1.429B
YoY Change 5.55% 197.83%
Goodwill $1.929B
YoY Change
Intangibles
YoY Change
Long-Term Investments $58.65M $860.0M
YoY Change -93.18% 217.81%
Other Assets $17.30M $31.40M
YoY Change -44.9% 16.3%
Total Long-Term Assets $4.232B $4.781B
YoY Change -11.49% 292.07%
TOTAL ASSETS
Total Short-Term Assets $2.614B $3.864B
Total Long-Term Assets $4.232B $4.781B
Total Assets $6.846B $8.646B
YoY Change -20.82% 309.3%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $89.40M $205.0M
YoY Change -56.39% 344.69%
Accrued Expenses $83.00M $51.80M
YoY Change 60.23% -36.13%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00
YoY Change
Long-Term Debt Due $22.57M $54.30M
YoY Change -58.43% 2072.0%
Total Short-Term Liabilities $319.7M $372.8M
YoY Change -14.24% 185.45%
LONG-TERM LIABILITIES
Long-Term Debt $477.8M $867.2M
YoY Change -44.9% 40.39%
Other Long-Term Liabilities $168.2M $1.408B
YoY Change -88.05% 1195.58%
Total Long-Term Liabilities $646.1M $2.276B
YoY Change -71.61% 213.26%
TOTAL LIABILITIES
Total Short-Term Liabilities $319.7M $372.8M
Total Long-Term Liabilities $646.1M $2.276B
Total Liabilities $1.818B $3.037B
YoY Change -40.14% 211.5%
SHAREHOLDERS EQUITY
Retained Earnings
YoY Change
Common Stock
YoY Change
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $5.028B $5.609B
YoY Change
Total Liabilities & Shareholders Equity $6.846B $8.646B
YoY Change -20.82% 309.3%

Cashflow Statement

Concept 2020 Q2 2019 Q2
OPERATING ACTIVITIES
Net Income -$108.5M -$185.9M
YoY Change -41.63% 107.28%
Depreciation, Depletion And Amortization $17.42M $13.59M
YoY Change 28.17% 116.01%
Cash From Operating Activities -$118.5M -$158.3M
YoY Change -25.11% 134.02%
INVESTING ACTIVITIES
Capital Expenditures $61.55M $211.8M
YoY Change -70.94% -235.38%
Acquisitions
YoY Change
Other Investing Activities -$361.4M -$186.1M
YoY Change 94.19% 601.92%
Cash From Investing Activities -$426.0M -$405.6M
YoY Change 5.03% 121.66%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net $6.345M $98.21M
YoY Change -93.54%
Cash From Financing Activities 247.3M -81.69M
YoY Change -402.73% -113.94%
NET CHANGE
Cash From Operating Activities -118.5M -158.3M
Cash From Investing Activities -426.0M -405.6M
Cash From Financing Activities 247.3M -81.69M
Net Change In Cash -327.3M -664.2M
YoY Change -50.72% -298.07%
FREE CASH FLOW
Cash From Operating Activities -$118.5M -$158.3M
Capital Expenditures $61.55M $211.8M
Free Cash Flow -$180.1M -$370.1M
YoY Change -51.34% -516.65%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2020Q2 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
P4Y3M3D
CY2020Q2 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Weighted Average Remaining Contractual Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1
P3Y8M1D
CY2020Q2 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
110416000
CY2019Q2 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
90482000
CY2020Q2 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
103921000
CY2019Q2 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
72192000
CY2020Q2 us-gaap Gross Profit
GrossProfit
6495000
CY2019Q2 us-gaap Gross Profit
GrossProfit
18290000
CY2020Q2 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
135392000
CY2019Q2 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
145647000
CY2020Q2 us-gaap Excise And Sales Taxes
ExciseAndSalesTaxes
8672000
CY2019Q2 us-gaap Excise And Sales Taxes
ExciseAndSalesTaxes
12909000
CY2020Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
-172376000
CY2020Q2 us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
-7189000
CY2020Q2 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
48205000
CY2020Q2 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-131360000
CY2020Q2 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-3038000
CY2020Q2 us-gaap Profit Loss
ProfitLoss
-128322000
CY2020Q2 us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
-19821000
CY2020Q2 us-gaap Net Income Loss
NetIncomeLoss
-108501000
CY2019Q2 us-gaap Noncontrolling Interest Increase From Subsidiary Equity Issuance
NoncontrollingInterestIncreaseFromSubsidiaryEquityIssuance
2680000
CY2019Q2 cgc Comprehensive Income Loss Net Of Tax Including Portion Attributable To Noncontrolling Interest
ComprehensiveIncomeLossNetOfTaxIncludingPortionAttributableToNoncontrollingInterest
-240185000
CY2019Q2 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
5809663000
CY2020Q2 us-gaap Profit Loss
ProfitLoss
-128322000
CY2019Q2 us-gaap Profit Loss
ProfitLoss
-194051000
CY2020Q2 us-gaap Depreciation
Depreciation
17415000
CY2019Q2 us-gaap Depreciation
Depreciation
13587000
CY2019Q2 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
7165000
CY2020Q2 us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
-7189000
CY2019Q2 us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
-1833000
CY2020Q2 cgc Share Based Compensation Including Amounts Recorded In Selling General And Administrative Expenses
ShareBasedCompensationIncludingAmountsRecordedInSellingGeneralAndAdministrativeExpenses
30685000
CY2019Q2 cgc Share Based Compensation Including Amounts Recorded In Selling General And Administrative Expenses
ShareBasedCompensationIncludingAmountsRecordedInSellingGeneralAndAdministrativeExpenses
87362000
CY2020Q2 us-gaap Restructuring Costs And Asset Impairment Charges
RestructuringCostsAndAssetImpairmentCharges
12794000
CY2019Q2 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
10267000
CY2019Q2 cgc Non Cash Foreign Currency
NonCashForeignCurrency
2834000
CY2020Q2 us-gaap Profit Loss
ProfitLoss
-128322000
CY2019Q2 us-gaap Profit Loss
ProfitLoss
-194051000
CY2020Q2 us-gaap Other Comprehensive Income Loss Financial Liability Fair Value Option After Tax And Reclassification Adjustment Attributable To Parent
OtherComprehensiveIncomeLossFinancialLiabilityFairValueOptionAfterTaxAndReclassificationAdjustmentAttributableToParent
-15360000
CY2019Q2 us-gaap Other Comprehensive Income Loss Financial Liability Fair Value Option After Tax And Reclassification Adjustment Attributable To Parent
OtherComprehensiveIncomeLossFinancialLiabilityFairValueOptionAfterTaxAndReclassificationAdjustmentAttributableToParent
14610000
CY2020Q2 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
-53124000
CY2019Q2 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
-60744000
CY2020Q2 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
-68484000
CY2019Q2 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
-46134000
CY2020Q2 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
363763347
CY2019Q2 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
346779156
CY2020Q2 us-gaap Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest
-196806000
CY2019Q2 us-gaap Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest
-240185000
CY2020Q2 us-gaap Comprehensive Income Net Of Tax Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest
-19821000
CY2019Q2 us-gaap Comprehensive Income Net Of Tax Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest
-8182000
CY2020Q2 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-176985000
CY2019Q2 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-232003000
CY2020Q1 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
5108120000
CY2020Q2 cgc Adjustments To Additional Paid In Capital Other Issuances Of Common Shares And Warrants Value
AdjustmentsToAdditionalPaidInCapitalOtherIssuancesOfCommonSharesAndWarrantsValue
-584000
CY2020Q2 cgc Stock Issued During Period Value Exercise Of Warrants
StockIssuedDuringPeriodValueExerciseOfWarrants
244990000
CY2019Q2 us-gaap Proceeds From Warrant Exercises
ProceedsFromWarrantExercises
427000
CY2020Q2 us-gaap Proceeds From Issuance Of Long Term Debt
ProceedsFromIssuanceOfLongTermDebt
4439000
CY2020Q2 us-gaap Repayments Of Long Term Debt
RepaymentsOfLongTermDebt
6345000
CY2019Q2 us-gaap Repayments Of Long Term Debt
RepaymentsOfLongTermDebt
98207000
CY2020Q2 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
247303000
CY2019Q2 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-81691000
CY2020Q2 us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
-30079000
CY2019Q2 us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
-18620000
CY2020Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-327306000
CY2019Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-664198000
CY2020Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
1303176000
CY2019Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
2480830000
CY2020Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
975870000
CY2019Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
1816632000
CY2020Q2 cgc Income Taxes Received
IncomeTaxesReceived
2000000
CY2020Q2 us-gaap Share Based Compensation
ShareBasedCompensation
30685000
CY2019Q2 us-gaap Share Based Compensation
ShareBasedCompensation
87362000
CY2020Q2 us-gaap Restructuring Costs And Asset Impairment Charges
RestructuringCostsAndAssetImpairmentCharges
12794000
CY2020Q2 us-gaap Operating Expenses
OperatingExpenses
178871000
CY2019Q2 us-gaap Operating Expenses
OperatingExpenses
233009000
CY2019Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
-214719000
CY2019Q2 us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
-1833000
CY2019Q2 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
32768000
CY2019Q2 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-183784000
CY2019Q2 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
10267000
CY2019Q2 us-gaap Profit Loss
ProfitLoss
-194051000
CY2019Q2 us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
-8182000
CY2019Q2 us-gaap Net Income Loss
NetIncomeLoss
-185869000
CY2020Q2 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.30
CY2019Q2 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.54
CY2020Q2 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
4722000
CY2020Q2 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
29140000
CY2020Q2 us-gaap Minority Interest Period Increase Decrease
MinorityInterestPeriodIncreaseDecrease
-11850000
CY2020Q2 us-gaap Noncontrolling Interest Increase From Subsidiary Equity Issuance
NoncontrollingInterestIncreaseFromSubsidiaryEquityIssuance
2809000
CY2020Q2 cgc Comprehensive Income Loss Net Of Tax Including Portion Attributable To Noncontrolling Interest
ComprehensiveIncomeLossNetOfTaxIncludingPortionAttributableToNoncontrollingInterest
-196806000
CY2020Q2 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
5180541000
CY2019Q1 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
7065708000
CY2019Q2 cgc Adjustments To Additional Paid In Capital Other Issuances Of Common Shares And Warrants Value
AdjustmentsToAdditionalPaidInCapitalOtherIssuancesOfCommonSharesAndWarrantsValue
-74000
CY2019Q2 cgc Stock Issued During Period Value Exercise Of Warrants
StockIssuedDuringPeriodValueExerciseOfWarrants
427000
CY2019Q2 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
16077000
CY2019Q2 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
84769000
CY2019Q2 cgc Adjustments To Additional Paid In Capital Acreage Warrant Modification
AdjustmentsToAdditionalPaidInCapitalAcreageWarrantModification
-1117639000
CY2019Q2 us-gaap Minority Interest Period Increase Decrease
MinorityInterestPeriodIncreaseDecrease
-2100000
CY2020Q2 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
16632000
CY2020Q2 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-3038000
CY2020Q2 cgc Non Cash Foreign Currency
NonCashForeignCurrency
8688000
CY2020Q2 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-17577000
CY2019Q2 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-13506000
CY2020Q2 us-gaap Other Receivables Net Current
OtherReceivablesNetCurrent
10793000
CY2020Q2 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
16059000
CY2019Q2 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
24009000
CY2020Q2 us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
10772000
CY2019Q2 us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
50716000
CY2020Q2 us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
3755000
CY2019Q2 us-gaap Payments To Acquire Intangible Assets
PaymentsToAcquireIntangibleAssets
7692000
CY2020Q2 us-gaap Short Term Investments
ShortTermInvestments
1060901000
CY2020Q2 us-gaap Available For Sale Debt Securities Amortized Cost Basis
AvailableForSaleDebtSecuritiesAmortizedCostBasis
1060890000
CY2020Q2 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
42222000
CY2020Q1 us-gaap Interest Receivable Current
InterestReceivableCurrent
10303000
CY2019Q2 us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
-12582000
CY2020Q2 cgc Increase Decrease In Other Operating Capital Net Including Non Cash Fair Value Adjustments
IncreaseDecreaseInOtherOperatingCapitalNetIncludingNonCashFairValueAdjustments
75090000
CY2019Q2 cgc Increase Decrease In Other Operating Capital Net Including Non Cash Fair Value Adjustments
IncreaseDecreaseInOtherOperatingCapitalNetIncludingNonCashFairValueAdjustments
13486000
CY2020Q2 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-118546000
CY2019Q2 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-158290000
CY2020Q2 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
61547000
CY2019Q2 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
211824000
CY2020Q2 us-gaap Payments To Acquire Intangible Assets
PaymentsToAcquireIntangibleAssets
3088000
CY2020Q2 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
917000
CY2020Q2 us-gaap Inventory Raw Materials And Supplies
InventoryRawMaterialsAndSupplies
49581000
CY2020Q2 us-gaap Inventory Work In Process
InventoryWorkInProcess
260028000
CY2020Q2 us-gaap Inventory Finished Goods
InventoryFinishedGoods
80191000
CY2020Q2 us-gaap Inventory Net
InventoryNet
389800000
CY2020Q2 us-gaap Inventory Write Down
InventoryWriteDown
19386000
CY2020Q2 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
51202000
CY2020Q2 cgc Prepaid Deposits Current
PrepaidDepositsCurrent
18752000
CY2020Q2 cgc Prepaid Inventory Current
PrepaidInventoryCurrent
17160000
CY2020Q2 us-gaap Other Assets Current
OtherAssetsCurrent
11248000
CY2020Q2 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
98362000
CY2020Q2 us-gaap Proceeds From Sale Of Intangible Assets
ProceedsFromSaleOfIntangibleAssets
18337000
CY2020Q2 us-gaap Payments For Proceeds From Short Term Investments
PaymentsForProceedsFromShortTermInvestments
382486000
CY2019Q2 us-gaap Payments For Proceeds From Short Term Investments
PaymentsForProceedsFromShortTermInvestments
-687818000
CY2019Q2 us-gaap Payments To Acquire Equity Method Investments
PaymentsToAcquireEquityMethodInvestments
2824000
CY2020Q2 us-gaap Payments To Acquire Other Productive Assets
PaymentsToAcquireOtherProductiveAssets
2564000
CY2019Q2 us-gaap Payments To Acquire Other Productive Assets
PaymentsToAcquireOtherProductiveAssets
29414000
CY2019Q2 cgc Investment In Acreage Arrangement
InvestmentInAcreageArrangement
395190000
CY2020Q2 us-gaap Proceeds From Recoveries Of Loan Previously Charged Off
ProceedsFromRecoveriesOfLoanPreviouslyChargedOff
10000000
CY2020Q2 us-gaap Payment For Contingent Consideration Liability Investing Activities
PaymentForContingentConsiderationLiabilityInvestingActivities
4511000
CY2019Q2 us-gaap Payment For Contingent Consideration Liability Investing Activities
PaymentForContingentConsiderationLiabilityInvestingActivities
21447000
CY2020Q2 us-gaap Payments To Acquire Additional Interest In Subsidiaries
PaymentsToAcquireAdditionalInterestInSubsidiaries
125000
CY2019Q2 cgc Payments To Acquire Subsidiaries
PaymentsToAcquireSubsidiaries
425024000
CY2020Q2 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-425984000
CY2019Q2 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-405597000
CY2020Q2 us-gaap Payments Of Stock Issuance Costs
PaymentsOfStockIssuanceCosts
595000
CY2019Q2 us-gaap Payments Of Stock Issuance Costs
PaymentsOfStockIssuanceCosts
74000
CY2020Q2 cgc Proceeds From Issuance Of Shares By Subsidiary
ProceedsFromIssuanceOfSharesBySubsidiary
92000
CY2019Q2 cgc Proceeds From Issuance Of Shares By Subsidiary
ProceedsFromIssuanceOfSharesBySubsidiary
86000
CY2020Q2 us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
4722000
CY2019Q2 us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
16077000
CY2020Q2 us-gaap Proceeds From Warrant Exercises
ProceedsFromWarrantExercises
244990000
CY2020Q2 us-gaap Income Taxes Paid
IncomeTaxesPaid
408000
CY2020Q2 us-gaap Capital Expenditures Incurred But Not Yet Paid
CapitalExpendituresIncurredButNotYetPaid
17337000
CY2019Q2 us-gaap Capital Expenditures Incurred But Not Yet Paid
CapitalExpendituresIncurredButNotYetPaid
124427000
CY2020Q2 us-gaap Use Of Estimates
UseOfEstimates
<p style="text-align:justify;margin-top:12pt;margin-bottom:0pt;text-indent:4.52%;font-weight:bold;font-style:italic;font-family:Times New Roman;font-size:10pt;text-transform:none;font-variant: normal;">Use of estimates</p> <p style="text-align:justify;margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The preparation of these condensed interim consolidated financial statements and accompanying notes in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the amounts reported. Actual results could differ from those estimates.</p>
CY2020Q2 us-gaap Restructuring Costs And Asset Impairment Charges
RestructuringCostsAndAssetImpairmentCharges
12794000
CY2020Q2 us-gaap Cash
Cash
508047000
CY2020Q1 us-gaap Cash
Cash
679581000
CY2020Q2 us-gaap Cash Equivalents At Carrying Value
CashEquivalentsAtCarryingValue
467823000
CY2020Q1 us-gaap Cash Equivalents At Carrying Value
CashEquivalentsAtCarryingValue
623595000
CY2020Q2 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
975870000
CY2020Q1 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
1303176000
CY2020Q1 us-gaap Short Term Investments
ShortTermInvestments
673323000
CY2020Q1 us-gaap Available For Sale Debt Securities Amortized Cost Basis
AvailableForSaleDebtSecuritiesAmortizedCostBasis
673022000
CY2020Q1 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
51166000
CY2020Q2 us-gaap Interest Receivable Current
InterestReceivableCurrent
14215000
CY2020Q2 us-gaap Value Added Tax Receivable
ValueAddedTaxReceivable
5348000
CY2020Q1 us-gaap Value Added Tax Receivable
ValueAddedTaxReceivable
22982000
CY2020Q1 us-gaap Other Receivables Net Current
OtherReceivablesNetCurrent
5704000
CY2020Q2 us-gaap Accounts Notes And Loans Receivable Net Current
AccountsNotesAndLoansReceivableNetCurrent
72578000
CY2020Q1 us-gaap Accounts Notes And Loans Receivable Net Current
AccountsNotesAndLoansReceivableNetCurrent
90155000
CY2020Q1 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
655000
CY2020Q1 us-gaap Inventory Raw Materials And Supplies
InventoryRawMaterialsAndSupplies
75507000
CY2020Q1 us-gaap Inventory Work In Process
InventoryWorkInProcess
255934000
CY2020Q1 us-gaap Inventory Finished Goods
InventoryFinishedGoods
59645000
CY2020Q1 us-gaap Inventory Net
InventoryNet
391086000
CY2019Q2 us-gaap Inventory Write Down
InventoryWriteDown
4789000
CY2020Q1 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
41423000
CY2020Q1 cgc Prepaid Deposits Current
PrepaidDepositsCurrent
7773000
CY2020Q1 cgc Prepaid Inventory Current
PrepaidInventoryCurrent
21217000
CY2020Q1 us-gaap Other Assets Current
OtherAssetsCurrent
14681000
CY2020Q1 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
85094000
CY2020Q1 us-gaap Equity Method Investments
EquityMethodInvestments
65843000
CY2020Q1 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
1524803000
CY2020Q1 cgc Other Noncurrent Financial Asset
OtherNoncurrentFinancialAsset
249253000
CY2020Q2 cgc Other Financial Assets Additions
OtherFinancialAssetsAdditions
2600000
CY2020Q2 cgc Changes In Other Financial Asset Fair Value Through Profit Or Loss
ChangesInOtherFinancialAssetFairValueThroughProfitOrLoss
21807000
CY2020Q2 cgc Exercise Of Options On Investments In Other Financial Assets
ExerciseOfOptionsOnInvestmentsInOtherFinancialAssets
36000
CY2020Q2 cgc Other Noncurrent Financial Asset
OtherNoncurrentFinancialAsset
273624000
CY2020Q2 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
1896965000
CY2020Q1 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
1915412000
CY2020Q2 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
388297000
CY2020Q1 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
390609000
CY2020Q2 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
1508668000
CY2020Q2 cgc Equity Method Investment Share Of Net Income Loss
EquityMethodInvestmentShareOfNetIncomeLoss
-7189000
CY2020Q2 us-gaap Equity Method Investments
EquityMethodInvestments
58654000
CY2020Q2 us-gaap Finite Lived Intangible Assets Gross
FiniteLivedIntangibleAssetsGross
444210000
CY2020Q2 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
354864000
CY2020Q1 us-gaap Finite Lived Intangible Assets Gross
FiniteLivedIntangibleAssetsGross
470658000
CY2020Q1 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
392811000
CY2020Q1 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
476366000
CY2019Q1 us-gaap Goodwill
Goodwill
1489859000
CY2020 us-gaap Goodwill Purchase Accounting Adjustments
GoodwillPurchaseAccountingAdjustments
443724000
CY2020 cgc Goodwill Finalization Of Purchase Price Allocation
GoodwillFinalizationOfPurchasePriceAllocation
24990000
CY2020 us-gaap Goodwill Foreign Currency Translation Gain Loss
GoodwillForeignCurrencyTranslationGainLoss
45878000
CY2020Q1 us-gaap Goodwill
Goodwill
1954471000
CY2020Q2 us-gaap Goodwill Foreign Currency Translation Gain Loss
GoodwillForeignCurrencyTranslationGainLoss
-25053000
CY2020Q2 us-gaap Goodwill
Goodwill
1929418000
CY2020Q2 cgc Accrued Property Plant And Equipment
AccruedPropertyPlantAndEquipment
2576000
CY2020Q1 cgc Accrued Property Plant And Equipment
AccruedPropertyPlantAndEquipment
1173000
CY2020Q2 us-gaap Accrued Professional Fees Current
AccruedProfessionalFeesCurrent
15725000
CY2020Q1 us-gaap Accrued Professional Fees Current
AccruedProfessionalFeesCurrent
7677000
CY2020Q2 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
41036000
CY2020Q1 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
33415000
CY2020Q2 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
23644000
CY2020Q1 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
22729000
CY2020Q2 us-gaap Accrued Liabilities And Other Liabilities
AccruedLiabilitiesAndOtherLiabilities
82981000
CY2020Q1 us-gaap Accrued Liabilities And Other Liabilities
AccruedLiabilitiesAndOtherLiabilities
64994000
CY2020Q2 us-gaap Other Long Term Debt
OtherLongTermDebt
10069000
CY2020Q1 us-gaap Other Long Term Debt
OtherLongTermDebt
10533000
CY2020Q2 us-gaap Long Term Debt
LongTermDebt
500406000
CY2020Q1 us-gaap Long Term Debt
LongTermDebt
465415000
CY2020Q2 us-gaap Long Term Debt Current
LongTermDebtCurrent
22570000
CY2020Q1 us-gaap Long Term Debt Current
LongTermDebtCurrent
16393000
CY2020Q2 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
477836000
CY2020Q1 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
449022000
CY2020Q2 cgc Transfer Of Factoring Receivables
TransferOfFactoringReceivables
4342000
CY2020Q2 cgc Secured Borrowing Associated With Transfer Of Factoring Receivables
SecuredBorrowingAssociatedWithTransferOfFactoringReceivables
4439000
CY2020Q2 cgc Acquisition Consideration Related Liabilities Current
AcquisitionConsiderationRelatedLiabilitiesCurrent
52318000
CY2020Q2 cgc Acquisition Consideration Related Liabilities Noncurrent
AcquisitionConsiderationRelatedLiabilitiesNoncurrent
13749000
CY2020Q2 cgc Acquisition Consideration Related Liabilities
AcquisitionConsiderationRelatedLiabilities
66067000
CY2020Q1 cgc Acquisition Consideration Related Liabilities Current
AcquisitionConsiderationRelatedLiabilitiesCurrent
104028000
CY2020Q1 cgc Acquisition Consideration Related Liabilities Noncurrent
AcquisitionConsiderationRelatedLiabilitiesNoncurrent
9791000
CY2020Q1 cgc Acquisition Consideration Related Liabilities
AcquisitionConsiderationRelatedLiabilities
113819000
CY2020Q2 cgc Operating And Finance Lease Liability Current
OperatingAndFinanceLeaseLiabilityCurrent
38308000
CY2020Q2 cgc Operating And Finance Lease Liability Noncurrent
OperatingAndFinanceLeaseLiabilityNoncurrent
97010000
CY2020Q1 cgc Operating And Finance Lease Liability Noncurrent
OperatingAndFinanceLeaseLiabilityNoncurrent
120047000
CY2020Q1 cgc Operating And Finance Lease Liability
OperatingAndFinanceLeaseLiability
160403000
CY2020Q1 cgc Miscellaneous Liabilities Noncurrent
MiscellaneousLiabilitiesNoncurrent
2445000
CY2020Q2 cgc Minimum Royalty Obligations Current
MinimumRoyaltyObligationsCurrent
11437000
CY2020Q2 cgc Minimum Royalty Obligations Noncurrent
MinimumRoyaltyObligationsNoncurrent
49043000
CY2020Q2 cgc Minimum Royalty Obligations
MinimumRoyaltyObligations
60480000
CY2020Q1 cgc Miscellaneous Liabilities
MiscellaneousLiabilities
13754000
CY2020Q2 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
124757000
CY2020Q1 cgc Minimum Royalty Obligations Current
MinimumRoyaltyObligationsCurrent
9368000
CY2020Q1 cgc Minimum Royalty Obligations Noncurrent
MinimumRoyaltyObligationsNoncurrent
50445000
CY2020Q1 cgc Minimum Royalty Obligations
MinimumRoyaltyObligations
59813000
CY2020Q2 cgc Refund Liability Current
RefundLiabilityCurrent
8433000
CY2020Q2 cgc Refund Liability
RefundLiability
8433000
CY2020Q1 cgc Refund Liability Current
RefundLiabilityCurrent
17586000
CY2020Q1 cgc Refund Liability
RefundLiability
17586000
CY2020Q2 cgc Operating And Finance Lease Liability
OperatingAndFinanceLeaseLiability
135318000
CY2020Q1 cgc Operating And Finance Lease Liability Current
OperatingAndFinanceLeaseLiabilityCurrent
40356000
CY2020Q2 cgc Settlement Liability Current
SettlementLiabilityCurrent
1411000
CY2020Q2 cgc Settlement Liability Noncurrent
SettlementLiabilityNoncurrent
6636000
CY2020Q2 cgc Settlement Liability
SettlementLiability
8047000
CY2020Q1 cgc Settlement Liability Current
SettlementLiabilityCurrent
33162000
CY2020Q1 cgc Settlement Liability Noncurrent
SettlementLiabilityNoncurrent
7932000
CY2020Q1 cgc Settlement Liability
SettlementLiability
41094000
CY2020Q2 cgc Miscellaneous Liabilities Current
MiscellaneousLiabilitiesCurrent
12850000
CY2020Q2 cgc Miscellaneous Liabilities Noncurrent
MiscellaneousLiabilitiesNoncurrent
1801000
CY2020Q2 cgc Miscellaneous Liabilities
MiscellaneousLiabilities
14651000
CY2020Q1 cgc Miscellaneous Liabilities Current
MiscellaneousLiabilitiesCurrent
11309000
CY2020Q2 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
168239000
CY2020Q2 us-gaap Other Liabilities
OtherLiabilities
292996000
CY2020Q1 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
215809000
CY2020Q1 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
190660000
CY2020Q1 us-gaap Other Liabilities
OtherLiabilities
406469000
CY2020Q1 us-gaap Redeemable Noncontrolling Interest Equity Carrying Amount
RedeemableNoncontrollingInterestEquityCarryingAmount
69750000
CY2020Q2 us-gaap Net Income Loss Attributable To Redeemable Noncontrolling Interest
NetIncomeLossAttributableToRedeemableNoncontrollingInterest
-10663000
CY2020Q2 cgc Redeemable Noncontrolling Interest Change In Redemption Value
RedeemableNoncontrollingInterestChangeInRedemptionValue
22513000
CY2020Q2 us-gaap Redeemable Noncontrolling Interest Equity Carrying Amount
RedeemableNoncontrollingInterestEquityCarryingAmount
81600000
CY2020Q2 cgc Number Of Equity Financing
NumberOfEquityFinancing
0
CY2019Q2 cgc Number Of Equity Financing
NumberOfEquityFinancing
0
CY2020Q2 cgc Number Of Shares Issued Relating To Completion Of Acquisition Milestones
NumberOfSharesIssuedRelatingToCompletionOfAcquisitionMilestones
751922
CY2020Q2 us-gaap Business Acquisition Equity Interests Issued Or Issuable Number Of Shares Issued
BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued
1164339
CY2020Q2 cgc Other Issuances Of Common Shares Net Of Share Issuance Cost
OtherIssuancesOfCommonSharesNetOfShareIssuanceCost
26214000
CY2020Q2 cgc Business Acquisition Share Based Compensation Reserve
BusinessAcquisitionShareBasedCompensationReserve
-26798000
CY2019Q2 cgc Number Of Shares Issued Relating To Completion Of Acquisition Milestones
NumberOfSharesIssuedRelatingToCompletionOfAcquisitionMilestones
482321
CY2019Q2 us-gaap Business Acquisition Equity Interests Issued Or Issuable Number Of Shares Issued
BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued
482321
CY2019Q2 cgc Other Issuances Of Common Shares Net Of Share Issuance Cost
OtherIssuancesOfCommonSharesNetOfShareIssuanceCost
18600000
CY2019Q2 cgc Business Acquisition Share Based Compensation Reserve
BusinessAcquisitionShareBasedCompensationReserve
-18674000
CY2020Q1 us-gaap Class Of Warrant Or Right Outstanding
ClassOfWarrantOrRightOutstanding
146299443
CY2020Q1 cgc Warrants Average Exercise Price
WarrantsAverageExercisePrice
52.44
CY2020Q1 cgc Warrant Value
WarrantValue
2638951000
CY2020Q2 cgc Number Of Whole Warrants On Exercise Of Warrants
NumberOfWholeWarrantsOnExerciseOfWarrants
18876901
CY2020Q2 cgc Average Exercise Price On Warrant Exercised
AverageExercisePriceOnWarrantExercised
12.98
CY2020Q2 cgc Warrant Value Exercise Of Warrants
WarrantValueExerciseOfWarrants
-70266000
CY2020Q2 us-gaap Class Of Warrant Or Right Outstanding
ClassOfWarrantOrRightOutstanding
127422542
CY2020Q2 cgc Warrants Average Exercise Price
WarrantsAverageExercisePrice
58.29
CY2020Q2 cgc Warrant Value
WarrantValue
2568685000
CY2019Q1 us-gaap Class Of Warrant Or Right Outstanding
ClassOfWarrantOrRightOutstanding
107848322
CY2019Q1 cgc Warrants Average Exercise Price
WarrantsAverageExercisePrice
43.80
CY2019Q1 cgc Warrant Value
WarrantValue
1589925000
CY2019Q2 cgc Number Of Whole Warrants On Exercise Of Warrants
NumberOfWholeWarrantsOnExerciseOfWarrants
12060
CY2019Q2 cgc Average Exercise Price On Warrant Exercised
AverageExercisePriceOnWarrantExercised
35.36
CY2019Q2 cgc Warrant Value Exercise Of Warrants
WarrantValueExerciseOfWarrants
-470000
CY2019Q2 us-gaap Class Of Warrant Or Right Outstanding
ClassOfWarrantOrRightOutstanding
146290706
CY2019Q2 cgc Warrants Average Exercise Price
WarrantsAverageExercisePrice
52.44
CY2019Q2 cgc Warrant Value
WarrantValue
2638608000
CY2020Q2 cgc Financings Other Than Release Of Shares Related To Share Purchase Financing
FinancingsOtherThanReleaseOfSharesRelatedToSharePurchaseFinancing
0
CY2020Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
28892048
CY2020Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber
11559338
CY2020Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
35.04
CY2020Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice
31.60
CY2020Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
34.89
CY2020Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice
31.84
CY2020Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
0.0033
CY2019Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
0.0141
CY2020Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
0.76
CY2019Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
0.73
CY2020Q2 cgc Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Forfeiture Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedForfeitureRate
0.16
CY2019Q2 cgc Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Forfeiture Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedForfeitureRate
0.11
CY2020Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
12.31
CY2019Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
28.58
CY2019Q2 cgc Number Of Shares Issued Relating To Completion Of Acquisition Milestones
NumberOfSharesIssuedRelatingToCompletionOfAcquisitionMilestones
482321
CY2020Q2 cgc Share Based Compensation Number Of Shares To Be Issued On Completion Of Acquisition And Asset Purchase Milestones
ShareBasedCompensationNumberOfSharesToBeIssuedOnCompletionOfAcquisitionAndAssetPurchaseMilestones
4090709
CY2020Q2 cgc Fair Value Transfers Of Amounts Between Levels
FairValueTransfersOfAmountsBetweenLevels
0
CY2020Q2 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
2970000
CY2019Q2 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
10281000
CY2020Q2 cgc Number Of Shares Issued Relating To Completion Of Acquisition Milestones
NumberOfSharesIssuedRelatingToCompletionOfAcquisitionMilestones
751922
CY2020Q2 us-gaap Other Comprehensive Income Loss Before Tax
OtherComprehensiveIncomeLossBeforeTax
-68484000
CY2019Q2 us-gaap Other Comprehensive Income Loss Before Tax
OtherComprehensiveIncomeLossBeforeTax
-46134000
CY2019Q2 cgc Fair Value Transfers Of Amounts Between Levels
FairValueTransfersOfAmountsBetweenLevels
0
CY2020Q2 us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
119088000
CY2019Q2 us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
103391000
CY2020Q2 us-gaap Excise And Sales Taxes
ExciseAndSalesTaxes
8672000
CY2019Q2 us-gaap Excise And Sales Taxes
ExciseAndSalesTaxes
12909000
CY2020Q2 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
110416000
CY2019Q2 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
90482000
CY2020Q2 cgc Allowance For Estimated Returns And Price Adjustments
AllowanceForEstimatedReturnsAndPriceAdjustments
3400000
CY2019Q2 cgc Allowance For Estimated Returns And Price Adjustments
AllowanceForEstimatedReturnsAndPriceAdjustments
8000000
CY2020Q2 cgc Liability For Estimated Sales Returns And Price Adjustments
LiabilityForEstimatedSalesReturnsAndPriceAdjustments
8433000
CY2020Q1 cgc Liability For Estimated Sales Returns And Price Adjustments
LiabilityForEstimatedSalesReturnsAndPriceAdjustments
17586000
CY2020Q2 cgc Other Financial Assets Fair Value Adjustment
OtherFinancialAssetsFairValueAdjustment
-21807000
CY2019Q2 cgc Other Financial Assets Fair Value Adjustment
OtherFinancialAssetsFairValueAdjustment
41087000
CY2020Q2 cgc Acreage Arrangement Liability Fair Value Adjustment
AcreageArrangementLiabilityFairValueAdjustment
-35000000
CY2020Q2 cgc Convertible Notes Fair Value Adjustment
ConvertibleNotesFairValueAdjustment
-20334000
CY2019Q2 cgc Convertible Notes Fair Value Adjustment
ConvertibleNotesFairValueAdjustment
31446000
CY2020Q2 us-gaap Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
-35369000
CY2019Q2 us-gaap Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
-24892000
CY2020Q2 us-gaap Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Liability1
BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1
-39983000
CY2019Q2 us-gaap Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Liability1
BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1
1570000
CY2020Q2 cgc Interest Income
InterestIncome
8993000
CY2019Q2 cgc Interest Income
InterestIncome
22718000
CY2020Q2 us-gaap Interest Expense
InterestExpense
1155000
CY2019Q2 us-gaap Interest Expense
InterestExpense
1206000
CY2020Q2 us-gaap Foreign Currency Transaction Gain Loss Realized
ForeignCurrencyTransactionGainLossRealized
-5959000
CY2019Q2 us-gaap Foreign Currency Transaction Gain Loss Realized
ForeignCurrencyTransactionGainLossRealized
-2856000
CY2020Q2 cgc Other Miscellaneous Non Operating Income Expense Net
OtherMiscellaneousNonOperatingIncomeExpenseNet
4501000
CY2019Q2 cgc Other Miscellaneous Non Operating Income Expense Net
OtherMiscellaneousNonOperatingIncomeExpenseNet
431000
CY2020Q2 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
48205000
CY2019Q2 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
32768000
CY2019Q2 us-gaap Warrants And Rights Outstanding Maturity Date
WarrantsAndRightsOutstandingMaturityDate
2023-11-01
CY2020Q2 us-gaap Number Of Operating Segments
NumberOfOperatingSegments
2

Files In Submission

Name View Source Status
0001564590-20-038957-index-headers.html Edgar Link pending
0001564590-20-038957-index.html Edgar Link pending
0001564590-20-038957.txt Edgar Link pending
0001564590-20-038957-xbrl.zip Edgar Link pending
cgc-10q_20200630.htm Edgar Link pending
cgc-10q_20200630_htm.xml Edgar Link completed
cgc-20200630.xsd Edgar Link pending
cgc-20200630_cal.xml Edgar Link unprocessable
cgc-20200630_def.xml Edgar Link unprocessable
cgc-20200630_lab.xml Edgar Link unprocessable
cgc-20200630_pre.xml Edgar Link unprocessable
cgc-ex311_9.htm Edgar Link pending
cgc-ex312_8.htm Edgar Link pending
cgc-ex321_7.htm Edgar Link pending
cgc-ex322_6.htm Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xlsx Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R100.htm Edgar Link pending
R101.htm Edgar Link pending
R102.htm Edgar Link pending
R103.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R53.htm Edgar Link pending
R54.htm Edgar Link pending
R55.htm Edgar Link pending
R56.htm Edgar Link pending
R57.htm Edgar Link pending
R58.htm Edgar Link pending
R59.htm Edgar Link pending
R6.htm Edgar Link pending
R60.htm Edgar Link pending
R61.htm Edgar Link pending
R62.htm Edgar Link pending
R63.htm Edgar Link pending
R64.htm Edgar Link pending
R65.htm Edgar Link pending
R66.htm Edgar Link pending
R67.htm Edgar Link pending
R68.htm Edgar Link pending
R69.htm Edgar Link pending
R7.htm Edgar Link pending
R70.htm Edgar Link pending
R71.htm Edgar Link pending
R72.htm Edgar Link pending
R73.htm Edgar Link pending
R74.htm Edgar Link pending
R75.htm Edgar Link pending
R76.htm Edgar Link pending
R77.htm Edgar Link pending
R78.htm Edgar Link pending
R79.htm Edgar Link pending
R8.htm Edgar Link pending
R80.htm Edgar Link pending
R81.htm Edgar Link pending
R82.htm Edgar Link pending
R83.htm Edgar Link pending
R84.htm Edgar Link pending
R85.htm Edgar Link pending
R86.htm Edgar Link pending
R87.htm Edgar Link pending
R88.htm Edgar Link pending
R89.htm Edgar Link pending
R9.htm Edgar Link pending
R90.htm Edgar Link pending
R91.htm Edgar Link pending
R92.htm Edgar Link pending
R93.htm Edgar Link pending
R94.htm Edgar Link pending
R95.htm Edgar Link pending
R96.htm Edgar Link pending
R97.htm Edgar Link pending
R98.htm Edgar Link pending
R99.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending